… ‘3 Also, few studies have assessed the effect of aspirin … Similar effects were also observed
among the 3531 patients with … cost~effectiveness analysis. Am J Med 2004;116:797-806. 18…

… The incremental cost-effectiveness ratio per quality-adjusted … All prescribed medications
including antiplatelet agents (… safe and having a favorable side effect profile. One of the major …

… This paper assesses the cost-effectiveness of rivaroxaban plus … estimated the incremental
cost-effectiveness ratio (ICER) per … The objective was to assess the economic implications of …

… cost-effectiveness ratio assessment of additive CV treatments, … which antiplatelet therapy is
regarded as a treatment option … The results of this study suggest that antiplatelet therapy may …

… to assess the risks and benefits of vorapaxar as an add-on treatment to standard care antiplatelet
therapy, … A state transition-based model was developed to assess the impact of adding …

… -benefit profile, cost-effectiveness and overall evidence base … 73), which was similar to the
overall effect across all 10 trials (… ) and a formal test of interaction for this subgroup effect was …

… diseases, coronary artery diseases, and peripheral artery … antiplatelet therapy, anticoagulation,
or other antithrombotic … To assess the impact of the parameters, we evaluated the ICERs …

… or Dual-Antiplatelet Therapy trial is the only published randomised control trial assessing
DAPT … by enabling all interaction effects to be investigated, 128 choice sets are not appropriate …

… trial among patients with prior coronary artery disease (CAD) [30], as … was to compare
economic implications between treatments (… Assessing the generalizability of the AUGUSTUS trial …

… Peripheral arterial disease (PAD) is described as a condition … anti-platelet agent into
provincial formularies and the cost … in the forrn of an incremental cost-effectiveness ratio (CER), …